|
ZNF655 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.218980E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.576240E-03 |
| Normal-vs-Stage2 |
6.115600E-02 |
| Normal-vs-Stage3 |
4.714800E-01 |
| Normal-vs-Stage4 |
9.743000E-01 |
| Stage1-vs-Stage2 |
3.520600E-01 |
| Stage1-vs-Stage3 |
1.975380E-03 |
| Stage1-vs-Stage4 |
2.849600E-01 |
| Stage2-vs-Stage3 |
4.017800E-02 |
| Stage2-vs-Stage4 |
1.059360E-01 |
| Stage3-vs-Stage4 |
6.582400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.060180E-03 |
| Normal-vs-AfricanAmerican |
1.699960E-02 |
| Normal-vs-Asian |
6.162600E-01 |
| Caucasian-vs-AfricanAmerican |
5.098800E-01 |
| Caucasian-vs-Asian |
5.726800E-01 |
| AfricanAmerican-vs-Asian |
5.237000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.224500E-04 |
| Normal-vs-Female |
8.078700E-03 |
| Male-vs-Female |
7.208000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.015600E-01 |
| Normal-vs-Extreme_Weight |
2.748000E-02 |
| Normal-vs-Obese |
1.883800E-02 |
| Normal-vs-Extreme_Obese |
2.856000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.304000E-01 |
| Normal_Weight-vs-Obese |
4.277600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.604000E-01 |
| Extreme_Weight-vs-Obese |
6.883800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.715800E-01 |
| Obese-vs-Extreme_Obese |
9.627400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.762200E-04 |
| Normal-vs-Age(41-60Yrs) |
5.71289999999891E-05 |
| Normal-vs-Age(61-80Yrs) |
2.786300E-02 |
| Normal-vs-Age(81-100Yrs) |
7.843400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.858200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.872360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.042400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.395700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.057800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.156000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.22450000536756E-08 |
| Normal-VS-Type2 PRCC |
1.318350E-01 |
| Normal-VS-KIRP CIMP |
9.815800E-01 |
| Normal-VS-Unclassified PRCC |
6.719700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.99500005193931E-10 |
| Type1 PRCC-VS-KIRP CIMP |
5.537000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.780200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.761000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.284500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.424570E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.567000E-01 |
| Normal-vs-N1 |
7.711000E-01 |
| Normal-vs-N2 |
1.797900E-02 |
| N0-vs-N1 |
6.346600E-01 |
| N0-vs-N2 |
1.253420E-01 |
| N1-vs-N2 |
1.684410E-01 |
|
|
